- Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan
[作者:Zhang, YZ; Zhi, ZZ; Jiang, TY; Zhang, JH; Wang, ZY; Wang, SL,期刊:Journal of controlled release, 页码:257-263 , 文章类型: Article,,卷期:2010年145-3]
- The purpose of this study was to develop mesoporous silica nanoparticles (MSNs) loaded with a poorly water-soluble drug, intended to be orally administered, able to improve the dissolution rate and enhance the drug loadi...
- Prolonged gene silencing by combining siRNA nanogels and photochemical internalization
[作者:Raemdonck, K; Naeye, B; Hogset, A; Demeester, J; De Smedt, SC,期刊:Journal of controlled release, 页码:281-288 , 文章类型: Article,,卷期:2010年145-3]
- Small interfering RNAs (siRNAs) show potential for the treatment of a wide variety of pathologies with a known genetic origin through sequence-specific gene silencing. However, siRNAs do not have favorable drug-like prop...
- Intracellular FRET analysis of lipid/DNA complexes using flow cytometry and fluorescence imaging techniques
[作者:Schneider, S; Lenz, D; Holzer, M; Palme, K; Suss, R,期刊:Journal of controlled release, 页码:289-296 , 文章类型: Article,,卷期:2010年145-3]
- Gene therapy is a promising therapeutic concept for a large number of incurable diseases. Lipid/DNA complexes (lipoplexes) are used to deliver genes into cells. However, while large efforts have been made to investigate ...
- Topical and intravitreous administration of cationic nanoemulsions to deliver antisense oligonucleotides directed towards VEGF KDR receptors to the eye
[作者:Hagigit, T; Abdulrazik, M; Orucov, F; Valamanesh, F; Lambert, M; Lambert, G; Behar-Cohen, F; Benita, S,期刊:Journal of controlled release, 页码:297-305 , 文章类型: Article,,卷期:2010年145-3]
- Antisense oligonucleotides (ODNs) specific for VEGFR-2-(17 MER) and inhibiting HUVEC proliferation in-vitro were screened. One efficient sequence was selected and incorporated in different types of nanoemulsions the pote...
- PEGylation markedly enhances the in vivo potency of recombinant human non-glycosylated erythropoietin: A comparison with glycosylated erythropoietin
[作者:Wang, YJ; Hao, SJ; Liu, YD; Hu, T; Zhang, GF; Zhang, XA; Qi, QS; Ma, GH; Su, ZG,期刊:Journal of controlled release, 页码:306-313 , 文章类型: Article,,卷期:2010年145-3]
- Recombinant human non-glycosylated erythropoietin (rh-ngEpo) expressed in E. coil was attached to polyethylene glycol (PEG) chains with different sizes and structures. The pharmacokinetic properties and in vivo potency o...
- Endocytosis of nanomedicines
[作者:Sahay, G; Alakhova, DY; Kabanov, AV,期刊:Journal of controlled release, 页码:182-195 , 文章类型: Review,,卷期:2010年145-3]
- Novel nanomaterials are being developed to improve diagnosis and therapy of diseases through effective delivery of drugs, biopharmaceutical molecules and imaging agents to target cells in disease sites. Such diagnostic a...
- Controlled release nanoparticle-embedded coatings reduce the tissue reaction to neuroprostheses
[作者:Mercanzini, A; Reddy, ST; Velluto, D; Colin, P; Maillard, A; Bensadoun, JC; Hubbell, JA; Renaud, P,期刊:Journal of controlled release, 页码:196-202 , 文章类型: Article,,卷期:2010年145-3]
- Controlled release coatings were developed for neuroprostheses with the aim of combating the tissue reaction following implantation in the brain. The coatings consist of poly(propylene sulfide) drug-eluting nanoparticles...
- Bioavailability in vivo of naltrexone following transbuccal administration by an electronically-controlled intraoral device: A trial on pigs
[作者:Campisi, G; Giannola, LI; Florena, AM; De Caro, V; Schumacher, A; Gottsche, T; Paderni, C; Wolff, A,期刊:Journal of controlled release, 页码:214-220 , 文章类型: Article,,卷期:2010年145-3]
- Naltrexone (NLX), an opioid antagonist, is widely used in the treatment of opiate addiction, alcoholism and smoking cessation. Its current peroral administration induces various adverse side effects and has limited effic...
|